Public-registry site landscape for NCT04387461, a Non Muscle Invasive Bladder Cancer study sponsored by CG Oncology, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04387461 (registry record) |
| Sponsor | CG Oncology, Inc. |
| Condition(s) | Non Muscle Invasive Bladder Cancer |
| Phase | PHASE2 |
| Listed sites | 19 |
| Site countries | United States, South Korea |
Eichor generates a preliminary site-risk snapshot for NCT04387461 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →